Shares of T2 Biosystems, Inc. (NASDAQ:TTOO – Get Free Report) passed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $0.00 and traded as high as $0.0005. T2 Biosystems shares last traded at $0.0005, with a volume of 2,129 shares.
T2 Biosystems Trading Down 16.7%
The stock has a market cap of $10,521.50, a PE ratio of -0.00 and a beta of 7.90.
About T2 Biosystems
T2 Biosystems, Inc is a diagnostics company focused on developing and commercializing rapid molecular tests for the detection of sepsis-causing pathogens and antimicrobial resistance. Its products are designed to identify infectious organisms directly from blood samples, helping healthcare providers make treatment decisions more quickly than with traditional culture-based methods.
The company’s portfolio includes the T2Dx Instrument, an automated diagnostic platform, along with tests such as T2Candida, T2Bacteria, T2Resistance and T2Biothreat.
Recommended Stories
- Five stocks we like better than T2 Biosystems
- 3 Defense Stocks Riding Nuclear, Missile, and Aerospace Demand
- SoFi Is Bypassing the Banking Bottleneck With Stablecoin Settlement
- These 3 Overlooked Stocks Have Big Money Behind Them
- Darden Restaurants Serves Up Fresh Catalysts for a Stock Price Rally
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
